Isolated Hepatic Perfusion with 200 mg Melphalan for Advanced Noncolorectal Liver Metastases
L.B.J. van Iersel(Maastricht University Medical Centre), Cornelis J.�H. van de Velde(Leiden University Medical Center), Alexander L. Vahrmeijer(Leiden University Medical Center), Ellen J. Hoekman(Leiden University Medical Center), Rob A.�E.�M. Tollenaar(Leiden University Medical Center), Peter J.K. Kuppen(Leiden University Medical Center), Els L. van Persijn van Meerten(Leiden University Medical Center), Henk H. Hartgrink(Leiden University Medical Center), Fred G. J. Tijl(Dutch Cancer Society), J.W.R. Nortier(Radboud University Nijmegen), Hans Gelderblom(Leiden University Medical Center)
Cited by 45
Related Papers
Pazopanib for metastatic soft-tissue sarcoma (PALETTE): a randomised, double-blind, placebo-controlled phase 3 trial
|The Lancet|2012|2.1k
Efficacy of MRI and Mammography for Breast-Cancer Screening in Women with a Familial or Genetic Predisposition
|New England Journal of Medicine|2004|1.7k
Cremophor EL
|European Journal of Cancer|2001|1.6k
Soft tissue and visceral sarcomas: ESMO–EURACAN Clinical Practice Guidelines for diagnosis, treatment and follow-up
|Annals of Oncology|2018|1.6k